Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio TRVI Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results VICI Properties Q1 2026 Earnings Strong EPS Beat Driven by Resilient Portfolio Performance